The reverse split is a compliance-driven event with no fundamental business catalyst. Monitor BIAF for potential selling pressure as the higher nominal price may reduce liquidity and attract short sellers. A bid-price compliance cure is not a growth signal — wait for revenue or product-stage updates before re-evaluating.
Price Chart
Executive Summary
bioAffinity Technologies filed an 8-K to execute a 1-for-15 reverse stock split, effective August 21, 2026, primarily to regain compliance with Nasdaq's minimum bid price requirement. Post-split, the company will have approximately 592,373 common shares outstanding. This is a mechanical capital structure adjustment with no accompanying financial data or business updates.
Key Facts
- 1-for-15 reverse stock split effective 4:01 p.m. ET on August 21, 2026; split-adjusted trading begins August 24, 2026.
- Post-split shares outstanding: approximately 592,373.
- Reverse split approved by stockholders at April 30, 2026 annual meeting.
- Primarily intended to bring the company into compliance with Nasdaq's minimum bid price requirement.
- CUSIP for common stock changes to 09076W406; warrants (BIAFW) CUSIP unchanged.
- No change to par value ($0.007 per share) or number of authorized shares.
- Proportionate adjustments to outstanding stock options, RSUs, and warrants.
Financial Impact
No revenue, earnings, cash flow, or guidance figures reported. Post-split share count reduces from approximately 8.89M to 592K shares.
Risk Factors
- Post-split liquidity may decrease, amplifying price volatility.
- Company may still face delisting if the bid price fails to stay above $1.00 for 10 consecutive trading days.
- Low market cap ($3M) and 0% analyst bullish consensus suggest limited institutional interest.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-039375 |
| Exhibit: ex99-1.htm | 0001493152-26-039375 |
| Exhibit: ex3-1.htm | 0001493152-26-039375 |
| Document: 0001493152-26-039375-index-headers.html | 0001493152-26-039375 |
| Document: 0001493152-26-039375-index.html | 0001493152-26-039375 |
| Document: 0001493152-26-039375.txt | 0001493152-26-039375 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | DEF 14A | $2.83 | awaiting T+60 | — | $2.96 (+4.59%) |
Oct 15, 2026 12d ago | 8-K | $3.96 | awaiting T+60 | — | $2.96 (−25.25%) |
Oct 13, 2026 14d ago | 8-K | $3.63 | awaiting T+60 | — | $2.96 (−18.34%) |
Oct 9, 2026 18d ago | 8-K | $3.90 | awaiting T+60 | — | $2.96 (+24.10%) |
Oct 9, 2026 18d ago | 424B5 | $4.73 | awaiting T+60 | — | $2.96 (+37.35%) |
Oct 9, 2026 18d ago | 424B5 | $4.73 | awaiting T+60 | — | $2.96 (−37.35%) |
Oct 8, 2026 19d ago | 8-K | $5.64 | awaiting T+60 | — | $2.96 (−47.52%) |
Oct 6, 2026 21d ago | 8-K | $6.06 | awaiting T+60 | — | $2.96 (−51.16%) |
Sep 30, 2026 27d ago | 8-K | $6.56 | awaiting T+60 | — | $2.96 (−54.88%) |
Sep 22, 2026 5w ago | 8-K | $8.56 | awaiting T+60 | — | $2.96 (−65.40%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers